Jasper Hellweg

Jasper Hellweg Analyst Performance

Security Analyst at Argus

Jasper Hellweg is a stock analyst at Argus focused in the healthcare sector, covering 26 publicly traded companies. Over the past year, Jasper Hellweg has issued 15 stock ratings, including strong buy, buy, and hold recommendations. While full access to Jasper Hellweg's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jasper Hellweg's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
51 Last 8 Years
Buy Recommendations
82.00% 41 Buy Ratings
Companies Covered
26 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy8.0%4 ratings
Buy74.0%37 ratings
Hold18.0%9 ratings
Sell0.0%0 ratings

Out of 50 total stock ratings issued by Jasper Hellweg at Argus, the majority (74.0%) have been Buy recommendations, followed by 18.0% Hold and 8.0% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
57.7% of companies on NYSE
15 companies
NASDAQ
42.3% of companies on NASDAQ
11 companies

Jasper Hellweg, an analyst at Argus, currently covers 26 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
24 companies
92.3%
Finance
1 company
3.8%
Communication Services
1 company
3.8%

Jasper Hellweg of Argus specializes in stock coverage within the Healthcare sector, with additional focus on Finance and Communication Services companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
9 companies
34.6%
PHARMACEUTICALS
8 companies
30.8%
HEALTHCARE PROVIDERS & SERVICES
3 companies
11.5%
LIFE SCIENCES TOOLS & SERVICES
2 companies
7.7%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
7.7%
FINANCIAL SERVICES
1 company
3.8%
INTERACTIVE MEDIA & SERVICES
1 company
3.8%

About Jasper Hellweg

Jasper covers the Pharmaceutical and Biotech industries in the Healthcare segment. Prior to joining Argus, he worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. Jasper began his career at Argus in the research department and has since widened his scope to include contributing to the Market Movers and Market Digest publications, the Vickers Weekly Insider Report, and Argus’ bespoke research on IPOs. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.
Follow on LinkedIn

Jasper Hellweg's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
11/12/2026Set Price Target$170.26$190.00
Amgen Inc. stock logo
AMGN
Amgen
11/12/2026Boost Price Target$468.11$515.00Buy
Fiserv, Inc. stock logo
FISV
Fiserv
11/4/2026Upgrade$58.40$72.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
11/3/2026Initiated Coverage$150.19Strong-Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,432.68$1,550.00Buy
Biogen Inc. stock logo
BIIB
Biogen
10/29/2026Upgrade$244.05$280.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/1/2026Upgrade$758.27$850.00Buy
Viatris Inc. stock logo
VTRS
Viatris
9/8/2026Boost Price Target$16.88$20.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
9/3/2026Boost Price Target$214.64$235.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/25/2026Boost Price Target$150.67$170.00Buy
Amgen Inc. stock logo
AMGN
Amgen
8/19/2026Boost Price Target$429.74$460.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
8/11/2026Boost Price Target$130.72$145.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
8/5/2026Upgrade$65.84$75.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
5/27/2026Downgrade$80.36Hold
Amgen Inc. stock logo
AMGN
Amgen
2/6/2026Boost Price Target$376.19$400.00Buy
Baxter International Inc. stock logo
BAX
Baxter International
10/31/2025Downgrade$19.17Hold
Zoetis Inc. stock logo
ZTS
Zoetis
9/9/2025Reiterated Rating$151.26$190.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
6/30/2025Downgrade$521.00Hold
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
4/25/2025Upgrade$48.45Hold
Biogen Inc. stock logo
BIIB
Biogen
4/4/2025Downgrade$130.71Hold
Baxter International Inc. stock logo
BAX
Baxter International
2/24/2025Upgrade$34.61Buy
Perrigo Company plc stock logo
PRGO
Perrigo
1/14/2025Downgrade$24.33Hold
Moderna, Inc. stock logo
MRNA
Moderna
12/18/2024Downgrade$40.76Hold